Cardiotoxicity and cardioprotection in breast cancer chemotherapy. The role of dexrazoxane.
Venturini
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D011929:Razoxane / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D011929:Razoxane